IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. - Wikidata - wikimedia - TriplyDB

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

http://www.wikidata.org/entity/Q34786724

about

Cell death programs in Yersinia immunity and pathogenesis Burkholderia cepacia Complex Vaccines: Where Do We Go from here?Omics strategies for revealing Yersinia pestis virulence In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils.TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague IFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense.Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.Immunity to infection in IL-17-deficient mice and humans A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.Th17 cell based vaccines in mucosal immunity.Plague vaccines: current developments and future perspectives.Immunology of Yersinia pestis Infection.Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.

P2860

Q21131303-1D547195-761C-4E85-BC92-51905AC47205 Q26752346-4D381E52-2740-4713-93B4-22F56CED5B1A Q28710346-0E9A1C56-D269-42EF-AA05-3ECF3A8A175D Q30371862-83CF9A7E-82CE-4E59-8D0C-0F8A5D272606 Q33603015-B49AD602-AE12-4F9F-AB58-867FB31BCCE0 Q33607420-E4782DF5-F5B9-42AA-A623-CC4ACCE94497 Q33650538-8787AA47-2269-4031-A0DB-0882DA606538 Q34163944-E5560BCB-A306-462B-BBBA-C11AEE2950A9 Q34298699-A6B6F0C2-A70C-4B7B-990C-ECE180B09CB9 Q35043536-9351E16B-5F3B-4309-B3DF-691A05FFF111 Q35091255-5866B3CA-187E-49B5-95BE-9130D335CCA4 Q35418294-481D3C8A-F8A2-44F3-9796-97501F99170F Q35439470-128DBC5B-FC43-48EB-905D-3DB1162C1546 Q35810279-4480526C-094A-4BD1-9713-C637FBBF8880 Q36277359-60F0D346-94B0-40EE-892D-0AED928EAFC8 Q36288336-435DD48D-9337-4827-9C95-07BF093B2D2B Q36316792-5EFC93F0-F2B2-4364-812C-78777CAF5ED1 Q36372952-AA7858D2-EBA8-4337-BE4A-081289161D64 Q36669812-223DF89D-CB61-4703-987E-0BF0E72A79CE Q36911486-2D755037-D1DF-44A6-BEDC-1DBB826E7C04 Q37037708-B1745B18-9246-4AE2-A865-49FF9356C032 Q37067254-CCC6651A-66E0-414B-B4F4-01AE2CED0FAE Q37405767-6303F6A6-CC54-4D4F-8D64-AF742BEB4C0B Q38106558-6E3A4ECC-757D-4A96-B7B8-01BDD0D39354 Q38514208-CE2464D6-69D8-494F-ADDB-EB2C0547E7DF Q40512106-D8F9FA3E-243D-47B3-9C93-5077AA691E06 Q40557637-0E41CA60-9AA7-4A94-B6CC-5FAA332AEDC0 Q41400297-E5CE7C81-4175-4A32-80E6-70B4E7CB528D Q46463260-36B9F3A2-C752-483E-B6BF-F76E8230A289 Q47293934-3E2D5A99-3BA9-4695-968E-982E8C688938 Q55361721-3432F86A-79AE-421C-8388-F1441FD7D453

P2860

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

http://www.wikidata.org/entity/Q34786724

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@ast

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@en

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@nl

type

label

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@ast

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@en

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@nl

prefLabel

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@ast

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@en

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@nl

P1433

Q34786724-293CA4B9-2690-4E6E-B711-B4045CC98E8D

P1476

Q34786724-7D0D6CBD-A84C-4EA9-B98D-E314472DF9F6

P2093

Q34786724-67568A39-4F7A-44F4-85C2-406C178283CE

Q34786724-80E431D4-2FF3-42CE-A130-37039AC694B3

Q34786724-AE179D1E-1327-41B2-8F55-B24E78685C2E

Q34786724-EFD2BBAA-7E08-410B-ABE4-E6BFC3501EF1

P2860

Q34786724-07F51B04-142A-4A2D-A883-91BCFF03DB87

Q34786724-08CE98AC-ED71-40CB-BDF8-1481D55E1056

Q34786724-099E7C82-D777-49A2-AC05-888AC357A790

Q34786724-0AD2DD03-62F1-4DEA-A270-B69DA4AD98DD

Q34786724-1662CC89-D385-48CD-A519-4C8A49CA0F82

Q34786724-1F29DA3E-41F0-4484-A05E-2E78AC62DB4C

Q34786724-22BADAEA-E89E-452B-97AE-368773C9E427

Q34786724-246BE0C4-F69E-4EF6-94CE-1509376015EA

Q34786724-2627DAD4-CDF0-446F-978B-1B80A611E165

Q34786724-29AFABA1-E771-4B7E-9999-340D4C43CD4C

P304

Q34786724-08BE5ACB-2F36-4284-BF29-A1387C4FD45C

P31

Q34786724-F915309B-BC6B-48C1-86A2-D36BAC690E95

P356

Q34786724-502438D1-AAE8-41C1-8E7E-48A49DA27EDE

P407

Q34786724-0645AED0-8DB9-4784-BA27-5A07941294E5

P433

Q34786724-56875244-32CE-41D2-9517-67F9CC4BFCB2

P478

Q34786724-4342E4F8-FC34-4774-9F67-D16AA0486A8F

P577

Q34786724-966F3204-3D99-47EF-92FD-5C916C99138A

P5875

Q34786724-D76C10BF-782B-4772-80D7-F3A3AD2B9C8E

P698

Q34786724-B49DEFAF-8744-4301-BF28-03B0E4ADAAC9

P921

Q34786724-A2438459-F3E6-4F5F-8E1F-0B731DEBD6AB

P932

Q34786724-9E13BC16-729B-4E16-A6B3-C8FC49C0A471

P356

JIMMUNOL.1003303

P1433

Journal of Immunology

P1476

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

@en

P2093

Frank M Szaba

http://www.w3.org/2001/XMLSchema#string

Jr-Shiuan Lin

http://www.w3.org/2001/XMLSchema#string

Lawrence W Kummer

http://www.w3.org/2001/XMLSchema#string

Stephen T Smiley

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A

The biological functions of T helper 17 cell effector cytokines in inflammation

Structure and signalling in the IL-17 receptor family

IL-17 and Th17 Cells

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Yersinia pestis--etiologic agent of plague

Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.

Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

P304

1675-1684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1003303

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49697347

http://www.w3.org/2001/XMLSchema#string

P698

21172869

http://www.w3.org/2001/XMLSchema#string

P921

Yersinia pestis

P932

3075555

http://www.w3.org/2001/XMLSchema#string